Innovative Technology ProTom International has developed the Radiance 330® Proton Therapy System featuring compact design, customizable options, and industry-leading return on investment, making it highly appealing to centers seeking advanced yet space-efficient cancer treatment solutions.

Market Expansion Recent launches of the fixed-beam Proton Therapy System and collaborations with partners like Leo Cancer Care demonstrate ProTom's strategic efforts to broaden its product offerings and enhance system versatility, presenting opportunities for sales of complementary equipment and integration solutions.

Recent Funding & Growth With a significant funding round of $30 million and reported revenues between $25M and $50M, ProTom is positioned for growth, indicating a strong market presence and potential for increasing sales through strategic investments and expanding customer base.

Technology Adoption ProTom utilizes modern tech stacks and digital platforms, which suggest openness to integrating additional digital tools or software upgrades, offering avenues for sales of software solutions, maintenance, and technical support tailored to advanced proton therapy systems.

Strategic Partnerships Active collaborations with healthcare and imaging providers like Leo Cancer Care and Beyond Behnke’s showcase ProTom’s ability to create integrated patient-centered solutions, providing opportunities to sell complementary imaging systems, patient positioning platforms, and service contracts.